To include your compound in the COVID-19 Resource Center, submit it here.

Vyvanse: Phase IV data

Top-line data from the double-blind, international Phase IV Study SPD489-406 in 547 ADHD patients aged 13-17 years showed that once-daily

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE